Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome

Neuroendocrinology Letters

Volumn 35, Issue 7, 2014, Pages 577-585

  Maes, Michael ^a   Leunis, Jean Claude ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Laboratoire Ategis   (Belgium)

Author keywords

Antioxidants; Bacterial translocation; Chronic fatigue; Inflammation; ME CFS; Neuro immune; Oxidative and nitrosative stress

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ACETYLCYSTEINE; BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; CARNITINE; CURCUMIN; EPITOPE; GLUTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; NITROSO DERIVATIVE; NUTRACEUTICAL; OLEIC ACID; QUERCETIN; TAURINE; THIOCTIC ACID; UBIDECARENONE; ZINC; ANTIOXIDANT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; ATTENUATION; AUTOIMMUNITY; BACTERIAL TRANSLOCATION; CHRONIC FATIGUE SYNDROME; CITROBACTER KOSERI; CONTROLLED STUDY; FEMALE; FIBROMYALGIA AND FATIGUE RATING SCALE; GRAM NEGATIVE BACTERIUM; HAFNIA ALVEI; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; NITROSATIVE STRESS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; RATING SCALE; TREATMENT DURATION; AUTOIMMUNE DISEASE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; ANTIOXIDANTS; AUTOIMMUNE DISEASES; BACTERIAL TRANSLOCATION; EPITOPES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NITROSO COMPOUNDS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84924551182     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bodet D, Glaize G, Dabadie MP, Geffard M (2004). Immunological follow-up for multiple slerosis. Immuno-Analyse Biol Spec. 19:138-147.
2. Boullerne AL, Petry KG, Meynard M, Geffard M (1995). Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunoi. 60(1-2):117-124.
3. Boullerne A, Petry KG, Geffard M (1996). Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. J Neuroimmunoi. 65(1):75-81.
4. Boullerne AL, Rodriguez JJ, Touil T, Brochet B, Schmidt S, Abrous ND, Le Moal M, Pua JR, Jensen MA, Mayo W, Arnason BG, Petry KG (2002). Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci. 22(1):123-132.
5. Brucknerova I, Ujhazy E, Dubovicky M, Mach M (2013) Oxidative stress in twins. Neuro Endocrinol Lett. 34 Suppl 2:71-73.
6. Cordero MD, Cotan D, Del-Pozo-Martin Y, Carrion AM, De Miguel M, Bullon P, Sanchez-Alcazar JA (2012). Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition. 28(11-12):1200-1203.
7. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Int Med. 121:953-959.
8. Garate I, Garcia-Bueno B, Madrigal JL, Bravo L, Berrocoso E, Caso JR, Mico JA, Leza JC (2011). Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation. 8:151.
9. Garate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus ML, Mico JA, Leza JC (2013). Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry. 73(1):32-43.
10. Gupta A, Vij G, Sharma S, Tirkey N, Rishi P, Chopra K (2009). Curcumin, a polyphenols antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology. 214(1):33-39.
11. Gupta A, Vij G, Chopra K (2010). Possible role of oxidative stress and immunological activation in mouse model of chronic fatigue syndrome and its attenuation by olive extract. J Neuroimmunoi. 226(1-2):3-7.
12. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, Delliaux S (2005). Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med. 257:299-310.
13. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ (2005). Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Rad Biol Med. 39:584-589.
14. Kontoangelos K, Papageorgiou CC, Raptis AE, Tsiotra P, Boutati E, Lambadiari V, Papadimitriou GN, Rabavilas AD, Dimitriadis G, Raptis SA (2014). Cytokines, diabetes mellitus and psychopathology: a challenging combination. Neuro Endocrinol Lett. 35(2):159-169.
15. Lin Y, Liu HL, Fang J, Yu CH, Xiong YK, Yuan K (2014). Anti-fatigue and vasoprotective effects of quercetin-3-O-gentiobiose on oxidative stress and vascular endothelial dysfunction induced by endurance swimming in rats. Food Chem Toxicol. 68:290-296.
16. Maes M, Leunis JC (2008). Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol Lett. 29(6):902-910.
17. Maes M, Twisk FN (2010). Chronic fatigue syndrome: Harvey and Wessely's (bio) psychosocial model versus a bio (psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med. 8:35.
18. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S (1999). Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 20(4):370-379.
19. Maes M, Mihaylova I, Leunis JC (2006). Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett. 27(5):615-621.
20. Maes M, Mihaylova I, Leunis JC (2007a). Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 28(6):861-867.
21. Maes M, Mihaylova I, Leunis JC (2007b). Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord. 99(1-3):237-240.
22. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009a). Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett. 30(4):470-476.
23. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2009b). Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett. 30:715-722.
24. Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M (2011). (Neuro) inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 35(3):659-663.
25. Maes M, Mihaylova I, Kubera M, Leunis JC, Twisk FN, Geffard M (2012a). IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myaigic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression. Metab Brain Dis. 27(4):415-423.
26. Maes M, Twisk FN, Kubera M, Ringel K, Leunis JC, Geffard M (2012b). Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J Affect Disord. 136(3):909-917.
27. Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M (2013). In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. J Affect Disord. 150(2):223-230.
28. Miyamae T, Seki M, Naga T, Uchino S, Asazuma H, Yoshida T, Lizuka Y, Kikuchi M, Imagawa T, Natsumeda Y, Yokota S, Yamamoto Y (2013). Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep. 18(1):12-19.
29. Moriya J, Chen R, Yamakawa J, Sasaki K, Ishigaki Y, Takahashi T (2011). Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull. 34(3):354-359.
30. Morris G, Maes M (2013a). A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab Brain Dis. 28(4):523-540.
31. Morris G, Maes M (2013b). Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics. BMC Med. 11:205.
32. Morris G, Maes M (2014). Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Curr Neuropharmacol. 12(2):168-185.
33. Morris G, Anderson G, Berk M, Maes M (2013a). Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. Mol Neurobiol. 48(3):883-903.
34. Morris G, Anderson G, Galecki P, Berk M, Maes M (2013b). A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med. 11:64.
35. Morris G, Berk M, Galecki P, Maes M (2014a). The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol Neurobiol. 49(2):741-756.
36. Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M (2014b). The Glutathione System: A New Drug Target in Neuroimmune Disorders. Mol Neurobiol. April 22. [Epub ahead of print] PubMed PMID: 24752591.
37. Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M (2014). Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev. 45:46-62.
38. Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y (2014). Neuroinflammation in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med. 55(6):945-950.
39. Sachdeva AK, Kuhad A, Tiwari V, Chopra K (2009). Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behav Brain Res. 205(2):414-420.
40. Sachdeva AK, Kuhad A, Tiwari V, Arora V, Chopra K (2010). Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic Clin Pharmacol Toxicol. 106(6):490-496.
41. Sachdeva AK, Kuhad A, Chopra K (2011). Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome. Brain Res Bull. 86(3-4):165-172.
42. Singal A, Kaur SJirkey N, Chopra K (2005). Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J Med Food. 8:47-52.
43. Singh A, Naidu PS, Gupta S, Kulkarni SK (2002a). Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food. 5:211-220.
44. Singh A, Garg V, Gupta S, Kulkarni SK (2002b). Role of antioxidants in chronic fatigue syndrome in mice. Ind J Exp Biol. 40:1240-1244.
45. Smirnova IV, Pall ML (2003). Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol. Cell. Biochem. 248:93-95.
46. Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, De Laurentis S, Affaitati G, De Cesare D, Giamberardino MA (2003). Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 335:151-154.
47. Wang SS, Wang YG, Chen HY, Wu ZP, Xie HG (2013). Expression of genes encoding cytokines and corticotropin releasing factor are altered by citalopram in the hypothalamus of post-stroke depression rats. Neuro Endocrinol Lett. 34(8):773-779.
48. Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG (2002). A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res. 52:501-509.